Published April 10, 2026 | Version v1
Preprint Open

Drugs for Weight Loss, Psychoanalysis for Weight Gain: An SAE Dimensional Analysis of Eating Disorders / 减肥靠吃药,增重靠心理分析:饮食障碍的SAE层级分析

Authors/Creators

Description

Description

This paper applies the SAE (Self-as-an-End) dimensional framework to eating disorders, analyzing obesity and anorexia nervosa as structurally symmetric pathologies. The core argument: the driver of excessive intake is primarily at 12DD (the drive layer), while the generator of anorexia nervosa is a cultural implant that has colonized the 14DD position (pseudo-14DD). 13DD (the conscious layer) serves mainly as an execution bridge. This yields a treatment principle: for 12DD problems, go lower (rewrite the 11DD habit substrate via eating rituals and intermittent fasting); for pseudo-14DD problems, go higher (with 15DD assistance, identify and clear the colonizer so genuine 14DD may emerge). The analysis covers GLP-1 pharmacology, the structural impasse of anorexia treatment, phase-transition window diagnostics (SAE Methodology VI) applied to IF and anorexia trial evidence, and — as speculative extension — identifies anorexia and nihilism as structurally isomorphic pseudo-14DD pathologies. SAE Biology Note 3 in the SAE Biology Series.

Keywords

SAE; Self-as-an-End; eating disorders; anorexia nervosa; binge eating disorder; obesity; GLP-1; semaglutide; tirzepatide; 12DD; 13DD; pseudo-14DD; 15DD; 11DD; habit; ritual; intermittent fasting; phase-transition window; nihilism; dimensional analysis; philosophy of medicine

License

Creative Commons Attribution 4.0 International (CC BY 4.0)

Language

English, Chinese (bilingual upload — two files)

Files to Upload

  1. Drugs for Weight Loss, Psychoanalysis for Weight Gain.pdf (English)
  2. 减肥靠吃药增重靠心理分析.pdf (Chinese)

Related Identifiers

Is supplement to:

  • DOI: 10.5281/zenodo.18528813 (SAE Paper 1 — foundational framework)

References:

  • DOI: 10.5281/zenodo.19492773 (SAE Biology Note 1 — Phase Transition Window in Metabolic Oncology)
  • DOI: 10.5281/zenodo.19464507 (SAE Methodology VI — Phase-Transition Windows and Experimental Design)
  • DOI: 10.5281/zenodo.19490707 (SAE Learning Series Paper 3 — 14DD and "cannot-not")
  • DOI: 10.5281/zenodo.19491926 (SAE Learning Series Paper 4 — 14DD to 15DD bridge)
  • DOI: 10.5281/zenodo.19321143 (SAE Psychoanalysis Series Paper 1)

Subjects

Medicine, Philosophy, Psychology, Neuroscience

Notes

SAE Biology Note 3. Third paper in the SAE Biology/Medical series. Bilingual (Chinese authoritative, English independent rewrite). Three-AI review process (ChatGPT deep research, Claude framework review, Gemini clinical review) integrated into final version.

Files

Drugs for Weight Loss, Psychoanalysis for Weight Gain.pdf

Files (13.4 MB)